MARKET

NSTG

NSTG

NanoString Tech
NASDAQ

Real-time Quotes | Nasdaq Last Sale

45.35
-0.67
-1.45%
After Hours: 45.35 0 0.00% 16:42 09/21 EDT
OPEN
45.21
PREV CLOSE
46.02
HIGH
46.08
LOW
43.40
VOLUME
373.93K
TURNOVER
--
52 WEEK HIGH
46.63
52 WEEK LOW
13.85
MARKET CAP
1.72B
P/E (TTM)
-26.1398
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
NanoString Launches Whole Transcriptome Atlas under GeoMx Technology Access Program and Names First GeoMx Premier Access Sites
NanoString announces expanded access to next-gen sequencing readout for GeoMx DSP.
Business Wire · 09/14 11:00
NanoString to Present at the 18th Annual Morgan Stanley Global Healthcare Conference
NanoString to webcast fireside chat presentation from the Morgan Stanley Global Healthcare Conference.
Business Wire · 09/09 21:01
Benzinga's Top Upgrades, Downgrades For September 9, 2020
Benzinga · 09/09 13:44
Morgan Stanley Initiates Coverage On NanoString Technologies with Equal-Weight Rating, Announces Price Target of $43
Morgan Stanley initiates coverage on NanoString Technologies (NASDAQ:NSTG) with a Equal-Weight rating and announces Price Target of $43.
Benzinga · 09/09 12:13
NanoString Announces New GeoMx COVID-19 Consortium, Part of the GeoMx Translational Leadership Network
NanoString announces GeoMx Translational Leadership Network and Spatial Biology Summit.
Business Wire · 09/09 10:00
NanoString to Present at the 2020 Baird Global Healthcare Conference
NanoString to participate in the Baird Global Healthcare Conference.
Business Wire · 09/03 21:01
10x Genomics Enjoys Investor Support As Stock Rebounds
10x Genomics went public in September 2019.The firm provides equipment and software for genetic research purposes.TXG has been sharply affected by the Covid-19 pandemic, but investor bullishness has pushed the stock nearly to its previous high.While the firm has strong prospects in a growing industry, I don't know whether the stock is a bargain or overvalued.
Seekingalpha · 08/14 23:34
UBS Maintains Buy on NanoString Technologies, Raises Price Target to $40
UBS maintains NanoString Technologies (NASDAQ:NSTG) with a Buy and raises the price target from $38 to $40.
Benzinga · 08/11 14:54
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average NSTG stock price target is 40.00 with a high estimate of 45.00 and a low estimate of 35.00.
EPS
Institutional Holdings
Institutions: 205
Institutional Holdings: 57.87M
% Owned: 152.35%
Shares Outstanding: 37.99M
TypeInstitutionsShares
Increased
50
5.64M
New
50
-356.05K
Decreased
34
4.60M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-1.45%
Healthcare Equipment & Supplies
-1.43%
Key Executives
Chairman/Independent Director
William Young
President/Chief Executive Officer/Director
R. Bradley Gray
Chief Financial Officer
K. Thomas Bailey
Senior Vice President/Director of Sales/Director of Marketing
J. Chad Brown
Senior Vice President/Director of Sales/Director of Marketing
John Brown
Senior Vice President
Joseph Beechem
Senior Vice President
David Ghesquiere
Independent Director
Elisha Finney
Independent Director
Robert Hershberg
Independent Director
Don Kania
Independent Director
Kirk Malloy
Independent Director
Gregory Norden
Independent Director
Charles Waite
  • Dividends
  • Splits
  • Insider Activity
No Data

Analyst Price Target

The average NSTG stock price target is 40.00 with a high estimate of 45.00 and a low estimate of 35.00.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About NSTG
NanoString Technologies, Inc. develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample. The Company's nCounter Analysis System is an automated, multi-application, digital detection and counting system, which directly profiles hundreds of molecules simultaneously using a barcoding technology. The Company markets systems and related consumables to researchers in academic, government and biopharmaceutical laboratories for use in understanding fundamental biology and the molecular basis of diseases, such as cancer, and to clinical laboratories and medical centers for diagnostic use.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of NanoString Technologies Inc stock information, including NASDAQ:NSTG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NSTG stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NSTG stock methods without spending real money on the virtual paper trading platform.